The role of lymphadenectomy in renal cell carcinoma

Current Opinion in Urology

Volumn 19, Issue 5, 2009, Pages 465-472

  Delacroix, Scott E ^a   Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lymph node dissection; Lymphadenectomy; Renal cell carcinoma; Staging; Therapeutic

Indexed keywords

INTERLEUKIN 2;

CANCER STAGING; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; NOMOGRAMS;

EID: 68949186463     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32832f0c48     Document Type: Review

References (33)

1. Blom JH, van Poppel H, Maréchal JM, et al. Radical nephrectomy with and without lymph-node dissection: final results of EORTC randomized phase 3 trial 30881. Eur Urol 2009; 55:28-34.
2. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101:297-301.
3. Canfield S, Kamat A, Sanchez-Ortiz R, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical TxN1 -2M0): the impact of aggressive surgical resection on patient outcome. J Urol 2006; 175:864-869.
4. Minervini A, Lilas L, Traversi M, et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 2001; 88:169-172.
5. Vasselli J, Yang J, Linehan M, et al. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol 2001; 166:68-72.
6. Pantuck A, Zisman A, Dorey F, etal. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003; 169:2076-2083. (Pubitemid 36576722)
7. Pantuck A, Zisman A, Dorey F, etal. Renal cell carcinoma with retroperitoneal lymph nodes. Cancer 2003; 97:2995-3002.
8. Joslyn S, Sirintrapun S, Konety B. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Urology 2005; 65:675-680.
9. Capitanio U, Jeldres C, Patard J, et al. Stage-specific effect of nodal metastases on survival in patients with nonmetastatic renal cell carcinoma. BJU Int 2009; 103:33-37.
10. Ward J, Blute M, Cheville J, et al. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol 2002; 168:56-60.
11. Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990; 144:243-245.
12. Giberti C, Oneto F, Martorana G, et al. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol 1997; 31:40-48.
13. Assouad J, Riquet M, Foucault C, etal. Renal lymphatic drainage and thoracic duct connections. Lymphology 2006; 39:26-32.
14. Parker AE. Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genitourinary system. Am J Anat 1935; 56:409-443.
15. Freedland S, De Kernion J. Role of lymphadenectomy for patients undergoing radical nephrectomy for renal cell carcinoma. Rev Urol 2006; 5: 191-195.
16. Chapman T, Sharma S, Shaozeng Z, et al. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal cell carcinoma. Urology 2008; 71:287-291.
17. Terrone C, Guercio S, De Luca S, etal. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 2003; 91:37-40.
18. Karakiewicz P, Trinh Q, Bhojani N, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007; 51:1616-1624.
19. Hutterer G, Patard J, Perotte P, et al. Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomo-gram. Int J Cancer 2007; 121:2556-2561.
20. Skinner DG. The value of regional lymph node dissection in genitourinary cancer. Semin Surg Oncol 1989; 5:235-239.
21. Jonasch E, Tannir N. Adjuvant and neoadjuvant therapy in renal cell carcinoma. Cancer J (Sudbury, Mass) 2008; 14:315-319.
22. Blute M, Leibovich B, Cheville J, et al. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 2004; 172:465-469.
23. Margulis V, Wood C. The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J 2008; 14:308-314.
24. Margulis V, Sanchez-Ortiz R, Tamboli P, et al. Renal cell carcinoma clinically involving adjacent organs. Cancer 2007; 109:2025-2030.
25. Frank I, Blute M, Cheville J, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168:2395-2400.
26. Ficarra V, Novara G, Galfano A, et al. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma. BJU Int 2009; 103:165-170.
27. Karakiewicz P, Suardi N, Capitanio U, et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol 2008; 55:287-295.
28. Guiliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 1990; 143:468-473.
29. Amin C, Wallen E, Pruthi R, etal. Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy. Urology 2008; 72:864-868.
30. Thomas A, Rini B, Lane B, et al. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol 2009; 181:518-523.
31. Shuch B, Riggs S, LaRochelle J, et al. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int 2008; 102:692-696.
32. Robert G, Gabbay G, Bram R, et al. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma. Eur Urol 2009. [Epub ahead of print]
33. Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res 2007; 13:697-702.